Government Intervention Requested for Poor HCV Detection and Treatment
NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is ‘Wake-Up Call’ for Washington
WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ — New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today.
The NVHR warns that without congressional action, millions of Americans infected with chronic hepatitis C virus – particularly African Americans – are at serious risk of developing cirrhosis, liver cancer, and liver failure and will add billions of dollars in unnecessary costs to our health care system every year.
Continue reading the entire article:
Vulnerable Amino Acid May be Hepatitis C's Downfall
Inovio's HCV Vaccine Trial Delivers Good Results